Low Response of the Thyroid Gland to Endogenous Thyrotropin Increased by Thyrotropin-Releasing Hormone in Patients with Euthyroid Graves' Disease

Euthyroid Graves' disease is defined as Graves' ophthalmopathy without hyperthyroidism, and the thyroid-stimulating antibody (TSAb) has been known to be a good marker for diagnosis. However, the question of why TSAb does not cause hyperthyroidism arises. To settle this, we examined thyroid responsiveness to endogenous thyrotropin (TSH) increased by thyrotropin-releasing hormone (TRH) in 23 patients with euthyroid Graves' disease. Nineteen patients (83%) had positive TSAb and 21 (91%) had at least one of the autoantibodies to the thyroid gland. Only one patient (4%) had positive thyroid-stimulation blocking antibody (TSBAb). Basal levels of free thyroxine (FT₄), free triiodothyronine (FT₃), and thyrotropin (TSH) in patients were not different from those in age- and sex-matched normal controls (n = 25). Response of TSH to TRH was normal; however, an increase of FT₃, either absolute or as a multiple of baseline, in the TRH test in these patients (0.46 ± 0.23 pg/mL, P < 0.001; 1.14 ± 0.09 fold, p < 0.001) was significantly lower than that in controls (0.86 ± 0.19 pg/ml; 1.26 ± 0.07 fold). There was no correlation between the Δ₃/ΔTSH ratio and TSAb activity. It is concluded that thyroid responsiveness in euthyroid Graves' disease is lower than in normal controls and this explains the euthyroid function in the patients even in the presence of TSAb.